Clinical Trial Update: Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial reporting reduction of left ventricular hypertrophy with eplerenone therapy in patients with hypertension and obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy
• Obstructive Sleep Apnea

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Hypertension,Essential, Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED